Do You Have a Combination Product, and Is It Drug-led or Device-led? Early Regulatory Insights
The Premier Consulting Blog
NOVEMBER 8, 2022
e) reveals more detail — and gray areas: Two or more regulated components, in one package (e.g., typical drug device, biologic device) Two or more separate components, co-packaged (e.g., e) reveals more detail — and gray areas: Two or more regulated components, in one package (e.g., Also see the FDA’s FAQs on this topic.)
52 
Let's personalize your content